Estimated Revenue: $1M to $10M
Funding Status: IPO
Headquarters: Hackensack, New Jersey, United States
Total Funding: 36800000.0
Last Funding Date: 2015-03-12
Investors Number: 4.0
Number Of Exists: Post-IPO Equity
Founded Date: 1985-01-01
Technology: Cancer
Industry: End-to-End Drug Development
Last Funding Type: Post-IPO Equity
Investor Type: Company
Investment Stage: N/A
Employee Number: 51-100